Device Week, April 17, 2020 – COVID-19 Impact On J&J Q1 2020 & Remote Monitoring

In this edition of Device Week, Medtech Insight’s Catherine Longworth chats to Reed Miller about how Johnson & Johnson’s medical device business has been impacted by COVID-19 in Q1. She also discusses with Marion Webb Abbott and Dexcom’s permission by US FDA to bring their CGM’s into hospital settings to monitor COVID-19 patients. For more information on Medtech Insight and to start a free trial, click here: http://bit.y/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: https://medtech.pharmaintelligence.informa.com/MT126594/JJ-Remains-Optimistic-Despite-5-Decline-In-FirstQuarter-Device-Sales https://medtech.pharmaintelligence.informa.com/MT126586/New-Frontier-COVID19-Crisis-Opens-Door-For-Dexcom-Abbott-To-Bring-CGMs-Into-Hospitals-For-First-Time